• The FDA Just Approved a New Way of Fighting Cancer Using Personalized Gene Therapy

    1 month ago - By Time

    Immune-based cancer treatments are surging forward as the Food and Drug Administration on Wednesday approved the second of a new technology called CAR T , this time to treat diffuse large b-cell lymphoma, a type of non-Hodgkin lymphoma. In August, the agency approved the first CAR T cell therapy , a type of gene therapy to treat acute lymphoblastic leukemia in children.
    CAR T cell therapy, which stands for chimeric antigen receptor T cell therapy, involves removing immune cells known as T cells, genetically engineering them to recognize proteins on cancer cells and target them for...
    Read more ...

     

  • FDA Approves Gilead Cancer Gene Therapy

    FDA Approves Gilead Cancer Gene Therapy

    1 month ago - By The Huffington Post

    The list price will be $373,000.
    Read more ...

     

  • US regulators approve 2nd gene therapy for blood cancer

    US regulators approve 2nd gene therapy for blood cancer

    1 month ago - By Daily Mail

    The Food and Drug Administration on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphomas.
    Read more ...

     

  • FDA Approves 2nd Gene Therapy For Leukemia

    1 month ago - By Web MD

    Yescarta fights a type of lymphoma; move is heralded as helping open 'new era' in medical care
    Read more ...